CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG had revenue of $1.46M in the quarter ending March 31, 2026, with 68.55% growth. This brings the company's revenue in the last twelve months to $3.10M, down -91.76% year-over-year. In the year 2025, CRISPR Therapeutics AG had annual revenue of $3.51M, down -90.59%.

• Revenue (ttm): $3.10M
• Revenue Growth: -91.76%
• P/S Ratio: 1,127.90
• Revenue / Employee: $10,440
• Employees: 393
• Market Cap: 4.63B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.51M	-33.80M	-90.59%
Dec 31, 2024	37.31M	-333.89M	-89.95%
Dec 31, 2023	371.21M	370.01M	30,885.48%
Dec 31, 2022	1.20M	-913.77M	-99.87%
Dec 31, 2021	914.96M	914.24M	127,154.94%
Dec 31, 2020	719.00K	-288.87M	-99.75%
Dec 31, 2019	289.59M	286.47M	9,169.85%
Dec 31, 2018	3.12M	-37.87M	-92.38%
Dec 31, 2017	41.00M	35.83M	693.90%
Dec 31, 2016	5.16M	4.92M	1,990.69%
Dec 31, 2015	247.00K	-	-
Dec 31, 2014	-	-	-

Data Source: Fiscal.ai Last updated: May 4, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error